Regulation of Insulin Action by Ceramide
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The sphingolipid ceramide negatively regulates insulin action by inhibiting Akt/protein kinase B (PKB), a serine/threonine kinase that is a central regulator of glucose uptake and anabolic metabolism. Despite considerable attention, the molecular mechanism accounting for this action of ceramide has remained both elusive and controversial. Herein we utilized deletion constructs encoding two different functional domains of Akt/PKB to identify which region of the enzyme conferred responsiveness to ceramide. Surprisingly the findings obtained with these separate domains reveal that ceramide blocks insulin stimulation of Akt/PKB by two independent mechanisms. First, using the isolated pleckstrin homology domain, we found that ceramide specifically blocks the translocation of Akt/PKB, but not its upstream activator phosphoinositide-dependent kinase-1, to the plasma membrane. Second, using a construct lacking this pleckstrin homology domain, which does not require translocation for activation, we found that ceramide stimulates the dephosphorylation of Akt/PKB by protein phosphatase 2A. Collectively these findings identify at least two independent mechanisms by which excessive ceramide accumulation in peripheral tissues could contribute to the development of insulin resistance. Moreover the results obtained provide a unifying theory to account for the numerous dissenting reports investigating the actions of ceramide toward Akt/PKB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lipotoxicity is characterized by the accumulation of lipid metabolites (ceramides and diacylglycerol) that interfere with insulin signaling, thus impairing insulin action (26,28).”
From Metabolic flexibility to lipid availability during exercise is enhanced in individuals with high insulin sensitivity (2018) · cites this paper as [26]
Citations
Cites
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
The sphingomyelin cycle and the second messenger function of ceramide.
Hannun, Y. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41834-5 · Cited by 1,235
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200008200 · Cited by 907
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Signal transduction of stress via ceramide
MATHIAS, S., PEÑA, L. A., & KOLESNICK, R. N. (1998) · Biochemical Journal · doi:10.1042/bj3350465 · Cited by 682
Role of Akt/protein kinase B in metabolism
Whiteman, E. L., Cho, H., & Birnbaum, M. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00662-8 · Cited by 676
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Ceramide activates heterotrimeric protein phosphatase 2A
Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82288-8 · Cited by 665
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617
Self-citation
Research works printed but not linked: 4
- Dobrzyn, 2002, Am. J. Physiol., 282, E277
- Wang, 2003, Methods Mol. Med., 83, 127
- Gray, 1999, Biochem. J., 344, 929, 10.1042/bj3440929 · doi:10.1042/bj3440929 · Paper page
- Jarvis, 1996, Clin. Cancer Res., 2, 1
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
“, IR kinase activation or PI3 kinase activation) (Schmitz-Peiffer et al., 1999; Stratford et al., 2004).”
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
“, DAGs and ceramide) have been shown to promote lipotoxicity and enhance hepatic insulin resistance (296), likely by inhibiting insulin signaling pathways (297, 298).”
BackgroundInsulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S.-Y., & Choi, C. S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,092
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
“…insulin stimulation of glucose uptake and glycogen synthesis by inhibiting phosphorylation and activation of Akt/protein kinase B (PKB) (Hajduch et al., 2001; Powell et al., 2003; Stratford et al., 2004; Summers et al., 1998; Teruel et al., 2001), a central mediator of insulin’s anabolic effects.”
BackgroundSelf-citationAdapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Role of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Adipose tissue and insulin resistance in obese
Ahmed, B., Sultana, R., & Greene, M. W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111315 · Cited by 1,047
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
“, ceramide impairs insulin signaling through activation of protein phosphatase 2”
BackgroundSelf-citationCeramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Self-citationGlatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
Holland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
Self-citationThe crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
The Origins and Drivers of Insulin Resistance
Johnson, A. M. F., & Olefsky, J. M. (2013) · Cell · doi:10.1016/j.cell.2013.01.041 · Cited by 643
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
“Ceramide signals to AKT/PKB through two independent effectors: protein phosphatase 2A (PP2A) and protein kinase C-z (PKCz) [58,60].”
BackgroundSelf-citationA Ceramide-Centric View of Insulin Resistance
Chavez, J. A., & Summers, S. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.002 · Cited by 610
Self-citationTestosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Pathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 499
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Self-citationSalminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.09.002 · Cited by 581
Korbecki, J., & Bajdak-Rusinek, K. (2019) · Inflammation Research · doi:10.1007/s00011-019-01273-5 · Cited by 509
“Activation of FFA1/GPR40 causes signal transduction through the PI3K =>PKB/Akt pathway, and the PLC =>PKC => p38/ERK–MAPK pathway, which causes phosphorylation and degradation of IκBα [181].”
BackgroundErtunc, M. E., & Hotamisligil, G. S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066514 · Cited by 488
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Chaurasia, B., Tippetts, T. S., Mayoral Monibas, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 450
Self-citationNeeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity
Lira, V. A., Benton, C. R., Yan, Z., & Bonen, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00755.2009 · Cited by 412
Swanton, C., Marani, M., Pardo, O., Warne, P. H., Kelly, G., Sahai, E., Elustondo, F., Chang, J., Temple, J., Ahmed, A. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.011 · Cited by 381
Ceramides in Metabolism: Key Lipotoxic Players
Chaurasia, B., & Summers, S. A. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-093815 · Cited by 343
Self-citationRoles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Quinville, B. M., Deschenes, N. M., Ryckman, A. E., & Walia, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115793 · Cited by 343
Lipid Use and Misuse by the Heart
Schulze, P. C., Drosatos, K., & Goldberg, I. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.306842 · Cited by 352
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Green, C. D., Maceyka, M., Cowart, L. A., & Spiegel, S. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.006 · Cited by 327
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
An update on sphingosine-1-phosphate and other sphingolipid mediators
Fyrst, H., & Saba, J. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.392 · Cited by 344
“Although much remains to be determined about the etiology of the SPL-null mouse phenotype, these findings suggest that sphingolipids may be important regulators of global lipid homeostasis and may play a part in the development of metabolic syndromes, as previously propose”
BackgroundMetabolic syndrome: from epidemiology to systems biology
Lusis, A. J., Attie, A. D., & Reue, K. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2468 · Cited by 344
Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise
Corcoran, M. P., Lamon-Fava, S., & Fielding, R. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.662 · Cited by 341
Lee, J. S., Pinnamaneni, S. K., Eo, S. J., Cho, I. H., Pyo, J. H., Kim, C. K., Sinclair, A. J., Febbraio, M. A., & Watt, M. J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01438.2005 · Cited by 325
Boon, J., Hoy, A. J., Stark, R., Brown, R. D., Meex, R. C., Henstridge, D. C., Schenk, S., Meikle, P. J., Horowitz, J. F., Kingwell, B. A., et al. (2013) · Diabetes · doi:10.2337/db12-0686 · Cited by 303
The Role of Ceramides in Insulin Resistance
Sokolowska, E., & Blachnio-Zabielska, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00577 · Cited by 297
Metabolic Messengers: ceramides
Summers, S. A., Chaurasia, B., & Holland, W. L. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0134-8 · Cited by 299
Self-citationPharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., et al. (2007) · Diabetes · doi:10.2337/db06-1619 · Cited by 301
Insulin signalling mechanisms for triacylglycerol storage
Czech, M. P., Tencerova, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 276
Cardiac lipid metabolism, mitochondrial function, and heart failure
Da Dalt, L., Cabodevilla, A. G., Goldberg, I. J., & Norata, G. D. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad100 · Cited by 258
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms—A Narrative Review
Wali, J. A., Jarzebska, N., Raubenheimer, D., Simpson, S. J., Rodionov, R. N., & O’Sullivan, J. F. (2020) · Nutrients · doi:10.3390/nu12051505 · Cited by 235
“In addition, the translocation of Akt to cell membrane is also blocked by ceramide [69,70].”
BackgroundInsulin Resistance: Metabolic Mechanisms and Consequences in the Heart
Abel, E. D., O’Shea, K. M., & Ramasamy, R. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241984 · Cited by 245
Role of intramyocelluar lipids in human health
Coen, P. M., & Goodpaster, B. H. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.009 · Cited by 252
Dimopoulos, N., Watson, M., Sakamoto, K., & Hundal, H. S. (2006) · Biochemical Journal · doi:10.1042/bj20060244 · Cited by 247
Poss, A. M., Maschek, J. A., Cox, J. E., Hauner, B. J., Hopkins, P. N., Hunt, S. C., Holland, W. L., Summers, S. A., & Playdon, M. C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131838 · Cited by 240
“The collection laboratory participates in the Centers for Disease Control Lipid Standardization Program (65).”
MethodSelf-citationThe effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241
“In C2C12 myoblasts, 3T3-L1 adipocytes and PC-12 cells, ceramides activate protein phosphatase 2A, leading to Akt dephosphorylation (Salinas et al., 2000; Cazzolli et al., 2001; Chavez et al., 2003; Stratford et al., 2004).”
BackgroundAdipocyte metabolism and obesity
Attie, A. D., & Scherer, P. E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800057-jlr200 · Cited by 225
Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications
Drosatos, K., & Schulze, P. C. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0133-0 · Cited by 216
Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes
Straczkowski, M., Kowalska, I., Baranowski, M., Nikolajuk, A., Otziomek, E., Zabielski, P., Adamska, A., Blachnio, A., Gorski, J., & Gorska, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0781-2 · Cited by 218
Chavez, J. A., Holland, W. L., Bär, J., Sandhoff, K., & Summers, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412769200 · Cited by 219
Self-citationCeramide and ceramide 1-phosphate in health and disease
Arana, L., Gangoiti, P., Ouro, A., Trueba, M., & Gómez-Muñoz, A. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-15 · Cited by 204
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntane, J., Rocha, M., & Victor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 197
“Activation of PKCβ1/2 activation via diacylglycerol can alter different proteins in the altering hemodynamics, vascular permeability, vascular endothelium growth factor (VEGF) production and redox signaling in the vessels [64].”
BackgroundInfluentialRaichur, S., Brunner, B., Bielohuby, M., Hansen, G., Pfenninger, A., Wang, B., Bruning, J. C., Larsen, P. J., & Tennagels, N. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.008 · Cited by 192
“, by stimulation of Akt dephosphorylation via protein phosphatase 2A (PP2A) and by blocking the translocation of Akt via PKCz [10].”
BackgroundAcid ceramidase and human disease
Park, J.-H., & Schuchman, E. H. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.019 · Cited by 195
Lipid metabolism and signaling in cardiac lipotoxicity
D'Souza, K., Nzirorera, C., & Kienesberger, P. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.016 · Cited by 188
Ceramide Recruits and Activates Protein Kinase C ζ (PKCζ) within Structured Membrane Microdomains
Fox, T. E., Houck, K. L., O'Neill, S. M., Nagarajan, M., Stover, T. C., Pomianowski, P. T., Unal, O., Yun, J. K., Naides, S. J., & Kester, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700082200 · Cited by 185
Ceramide 1-phosphate/ceramide, a switch between life and death
Gómez-Muñoz, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.011 · Cited by 186
Summers, S. A., & Nelson, D. H. (2005) · Diabetes · doi:10.2337/diabetes.54.3.591 · Cited by 185
“[23,60,62,64-66] While acute treatment with ceramides has these effects on insulin signaling, prolonged treatment of 3T3-L1 adipocytes with the sphingolipid was shown to downregulate GLUT4 expression.”
BackgroundSelf-citationPark, J.-W., Park, W.-J., Kuperman, Y., Boura-Halfon, S., Pewzner-Jung, Y., & Futerman, A. H. (2013) · Hepatology · doi:10.1002/hep.26015 · Cited by 169
Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
Chavez, J. A., & Summers, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.015 · Cited by 169
Self-citationde la Monte, S. M., Longato, L., Tong, M., & Wands, J. R. (2009) · PubMed · Cited by 190
Ko, H. J., Zhang, Z., Jung, D. Y., Jun, J. Y., Ma, Z., Jones, K. E., Chan, S. Y., & Kim, J. K. (2009) · Diabetes · doi:10.2337/db08-1361 · Cited by 159
Sphingolipids and glycerophospholipids – The “ying and yang” of lipotoxicity in metabolic diseases
Rodríguez‐Cuenca, S., Pellegrinelli, V., Campbell, M., Orešič, M., & Vidal‐Puig, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.01.002 · Cited by 160
Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
Li, X., Zhang, D., Vatner, D. F., Goedeke, L., Hirabara, S. M., Zhang, Y., Perry, R. J., & Shulman, G. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922169117 · Cited by 158
Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome
Rocha, M., Apostolova, N., Díaz‐Rúa, R., Muntané, J., & Víctor, V. M. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.03.004 · Cited by 163
“For example, PKCε contributes to lipid-induced IR through crosstalk with p70S6K and recently identified regulators of insulin signaling [32].”
BackgroundInfluentialCancer Treatment Strategies Targeting Sphingolipid Metabolism
Oskouian, B., & Saba, J. D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_13 · Cited by 162
Watt, M. J., & Hoy, A. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2011 · Cited by 142
Regulation of Autophagy and Its Associated Cell Death by “Sphingolipid Rheostat”
Taniguchi, M., Kitatani, K., Kondo, T., Hashimoto-Nishimura, M., Asano, S., Hayashi, A., Mitsutake, S., Igarashi, Y., Umehara, H., Takeya, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416552 · Cited by 140
Cellular and Molecular Mechanisms of Insulin Resistance
Chandrasekaran, P., & Weiskirchen, R. (2024) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-024-00056-3 · Cited by 141
Longato, L., Ripp, K., Setshedi, M., Dostálek, M., Akhlaghi, F., Branda, M., Wands, J. R., & de la Monte, S. M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/479348 · Cited by 141
“However, we focused our studies on the potential contributions of ceramides in chronic ALD because (1) ceramides have demonstrated roles in the pathogenesis of steatohepatitis in experimental models of chronic ethanol or high-fat diet feeding [10, 11]; (2) ceramides can promote insulin resistance, inflammation, and ox…”
BackgroundRoles of l-serine and sphingolipid synthesis in brain development and neuronal survival
Hirabayashi, Y., & Furuya, S. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.01.003 · Cited by 134
Contribution of specific ceramides to obesity-associated metabolic diseases
Hammerschmidt, P., & Brüning, J. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04401-3 · Cited by 142
Cardiovascular Networks: Systems-Based Approaches to Cardiovascular Disease
Lusis, A. J., & Weiss, J. N. (2010) · Circulation · doi:10.1161/circulationaha.108.847699 · Cited by 142
Sun, Q., Xing, X., Wang, H., Wan, K., Fan, R., Liu, C., Wang, Y., Wu, W., Wang, Y., & Wang, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115586 · Cited by 138
Gosejacob, D., Jäger, P. S., Dorp, K. V., Frejno, M., Carstensen, A., Köhnke, M., Degen, J., Dörmann, P., & Hoch, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691212 · Cited by 142
Ceramides and mitochondrial fatty acid oxidation in obesity
Fucho, R., Casals, N., Serra, D., & Herrero, L. (2016) · The FASEB Journal · doi:10.1096/fj.201601156r · Cited by 136
Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells
Bandet, C. L., Tan, S., Bourron, O., Stunff, H. L., & Hajduch, É. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030479 · Cited by 136
“Inhibition of PP2A activity (with the PP2A inhibitor okadaic acid) completely restored insulin-induced Akt phosphorylation, thus confirming the role of PP2A in the inhibition of insulin signaling in this muscle cell model [71,73,96] (Figure 2).”
BackgroundGlycosphingolipids and insulin resistance
Langeveld, M., & Aerts, J. M. F. G. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.03.002 · Cited by 132
Rovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 131
“Akt, protein kinase B; ApoB100, apolipoprotein B100; ER, endoplasmic reticulum; FAD, flavin adenine dinucleotide; FOXO, forkhead box; GSK3 b , glycogen synthase kinase 3 beta; I j K b , inhibitor of nuclear factor kappa-B kinase subunit beta; IRS1, insulin receptor substrate 1; JNK, c-Jun N-terminal kinase; mTOR, mamma…”
InfluentialJoung, S. M., Park, Z., Rani, S., Takeuchi, O., Akira, S., & Lee, J. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903534 · Cited by 126
Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS
Persson, X.-M. T., Błachnio-Zabielska, A. U., & Jensen, M. D. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008011 · Cited by 123
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Armandi, A., Rosso, C., Caviglia, G. P., & Bugianesi, E. (2021) · Metabolites · doi:10.3390/metabo11030155 · Cited by 126
Blouin, C. M., Prado, C., Takane, K. K., Lasnier, F., García-Ocaña, A., Ferré, P., Dugail, I., & Hajduch, É. (2009) · Diabetes · doi:10.2337/db09-0897 · Cited by 122
“In agreement with this, one study performed in 3T3-L1 adipocytes has shown that ceramide-activated PP2A was able to dephosphorylate a cytosolic insulinstimulated PKB/Akt construct lacking its PH domain (49).”
ResultRole of Caspase-1 in the Pathogenesis of Inflammatory-Associated Chronic Noncommunicable Diseases
Molla, M. D., Akalu, Y., Geto, Z., Dagnew, B., Ayelign, B., & Shibabaw, T. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s277457 · Cited by 131
Longato, L., Tong, M., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00934.x · Cited by 121
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 121
Role of ceramides in the pathogenesis of diabetes mellitus and its complications
Mandal, N. A., Grambergs, R. C., Mondal, K., Basu, S. K., Tahia, F., & Dagogo-Jack, S. E. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107734 · Cited by 117
Roles of Ceramides and Other Sphingolipids in Immune Cell Function and Inflammation
Albeituni, S., & Stiban, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_15 · Cited by 123
Brozinick, J. T., Hawkins, E., Bui, H. H., Kuo, M.-S., Tan, B., Kievit, P., & Grove, K. L. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.191 · Cited by 112
Muscle insulin resistance: assault by lipids, cytokines and local macrophages
Kewalramani, G., Bilan, P. J., & Klip, A. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833aabd9 · Cited by 129
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Mitrofanova, A. V., Mallela, S. K., Ducasa, G. M., Yoo, T., Rosenfeld-Gur, E., Zelnik, I. D., Molina, J., Santos, J. V., Ge, M., Sloan, A. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10584-4 · Cited by 109
Sphingolipids: players in the pathology of metabolic disease
Cowart, L. A. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.09.004 · Cited by 105
de la Monte, S. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111727 · Cited by 109
Metadata
- Authors
- Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A.
- Affiliations
- Colorado State University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Summers, Scott A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 279
- Issue
- 35
- Pages
- 36608-36615
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1995687483
- Cited by
- 410
- References
- 60
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 21 · 2023: 12 · 2022: 16 · 2021: 21 · 2020: 27 · 2019: 21 · 2018: 21 · 2017: 26 · 2016: 21 · 2015: 17 · 2014: 11 · 2013: 24 · 2012: 24
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5921 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R012 DK 58784, R01DK056166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- ceramide, insulin resistance, Akt/protein kinase B, pleckstrin homology domain, PDPK1, protein phosphatase 2A, Akt dephosphorylation, sphingolipids, glucose uptake, insulin signaling
- MeSH terms
- Animals, Cell Line, Cell Membrane, Ceramides, Enzyme Inhibitors, Gene Expression Regulation, Insulin, Microscopy, Fluorescence, Phosphorylation, Proto-Oncogene Proteins, Immunoblotting, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Protein Structure, Tertiary, DNA, Complementary, Microscopy, Confocal, Okadaic Acid, Phosphatidylinositol 3-Kinases, Catalytic Domain, Protein Transport, 3T3-L1 Cells, Proto-Oncogene Proteins c-akt, Mice, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.